Cancers detected prostate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Prostate Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Epithelial Cells Seminal Vesicles Breast Stromal Cells Neoplastic Cells, Circulating Chromosomes, Human, Pair 8 Cell Line HCT116 Cells

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic

Diseases45

Prostatic Neoplasms Prostatic Hyperplasia Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms Disease Progression Adenocarcinoma Ovarian Neoplasms Neoplasms, Hormone-Dependent Lung Neoplasms Neoplasms Prostatic Intraepithelial Neoplasia Colonic Neoplasms Stomach Neoplasms Genetic Predisposition to Disease Carcinoma Bone Neoplasms Pancreatic Neoplasms Neoplasm Recurrence, Local Urinary Bladder Neoplasms Cell Transformation, Neoplastic Uterine Cervical Neoplasms Prostatic Diseases Colorectal Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Rectal Neoplasms Neovascularization, Pathologic Prostatitis Endometrial Neoplasms Esophageal Neoplasms Disease Models, Animal Liver Neoplasms Precancerous Conditions Prostatic Neoplasms, Castration-Resistant Head and Neck Neoplasms Neoplasms, Radiation-Induced Neoplasms, Second Primary Carcinoma, Small Cell Mouth Neoplasms Neoplasms, Glandular and Epithelial Neoplastic Cells, Circulating Skin Neoplasms Genital Neoplasms, Female Gastrointestinal Neoplasms

Chemicals and Drugs65

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents RNA, Messenger Cancer Vaccines Antineoplastic Agents, Hormonal RNA, Small Interfering Tosyl Compounds DNA, Neoplasm Dihydrotestosterone Anticarcinogenic Agents Receptors, Estrogen Antigens, Neoplasm Finasteride Receptor, erbB-2 Antineoplastic Agents, Phytogenic Androgen Receptor Antagonists Tumor Suppressor Protein p53 Anilides Taxoids PTEN Phosphohydrolase Tumor Suppressor Proteins 5-alpha Reductase Inhibitors MicroRNAs RNA, Neoplasm Metribolone Flutamide Transcription Factors Testosterone Proto-Oncogene Proteins c-akt Paclitaxel Tamoxifen Fluorouracil Antibodies, Monoclonal DNA-Binding Proteins Cisplatin Receptors, Progesterone Glutamate Carboxypeptidase II Receptor, Epidermal Growth Factor Nitriles Azasteroids Proto-Oncogene Proteins 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Testosterone Congeners Nuclear Proteins DNA Primers Estrogens Enzyme Inhibitors Proto-Oncogene Proteins c-bcl-2 Glutathione S-Transferase pi Ki-67 Antigen Carcinogens Antimetabolites, Antineoplastic Cadherins BRCA2 Protein Deoxycytidine Protein Kinase Inhibitors Androgen-Binding Protein Protein-Serine-Threonine Kinases Membrane Proteins Racemases and Epimerases

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Early Detection of Cancer Prostatectomy Orchiectomy Transurethral Resection of Prostate Reverse Transcriptase Polymerase Chain Reaction Neoplasm Staging Prognosis Xenograft Model Antitumor Assays Neoplasm Transplantation Gene Expression Profiling Survival Analysis Neoplasm Grading Survival Rate Risk Follow-Up Studies Blotting, Western Retrospective Studies Transplantation, Heterologous Prospective Studies Risk Factors Risk Assessment Sensitivity and Specificity Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Registries Odds Ratio Combined Modality Therapy Disease-Free Survival Biopsy Digital Rectal Examination Oligonucleotide Array Sequence Analysis Tumor Burden Biopsy, Needle Transfection Multivariate Analysis SEER Program Tissue Array Analysis Polymerase Chain Reaction Treatment Outcome Predictive Value of Tests Drug Screening Assays, Antitumor Reproducibility of Results Kaplan-Meier Estimate Incidence Radiotherapy Molecular Targeted Therapy Questionnaires Logistic Models Chemotherapy, Adjuvant Clinical Trials as Topic Models, Biological Radiotherapy Dosage Immunoenzyme Techniques Cohort Studies Confidence Intervals Gene Knockdown Techniques Flow Cytometry Disease Models, Animal Brachytherapy Mammography Castration Case-Control Studies Immunotherapy Drug Administration Schedule In Situ Hybridization, Fluorescence Radiotherapy Planning, Computer-Assisted Genetic Therapy Real-Time Polymerase Chain Reaction Nomograms Palliative Care DNA Mutational Analysis

Psychiatry and Psychology1

Phenomena and Processes47

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Cell Proliferation Apoptosis Risk Drug Resistance, Neoplasm Sensitivity and Specificity Cell Survival Cell Division Down-Regulation Mutation Cell Growth Processes Odds Ratio DNA Methylation Genotype Cell Movement Signal Transduction Transfection Promoter Regions, Genetic Cell Cycle Up-Regulation Dose-Response Relationship, Drug Polymorphism, Genetic Gene Silencing Genes, Tumor Suppressor RNA Interference Base Sequence Gene Expression Time Factors Genes, BRCA1 Diet Genes, Neoplasm Phosphorylation Germ-Line Mutation Phenotype Alleles Transcription, Genetic Genes, p53 Drug Synergism Epithelial-Mesenchymal Transition Chromosomes, Human, Pair 8 Epigenesis, Genetic Nomograms Tumor Microenvironment Genes, BRCA2 CpG Islands Gene Fusion

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science8

Survival Rate Registries SEER Program Incidence Questionnaires Base Sequence Molecular Sequence Data Radiotherapy Planning, Computer-Assisted

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care32

Survival Analysis Survival Rate Risk Follow-Up Studies Retrospective Studies Prospective Studies Risk Factors Risk Assessment National Cancer Institute (U.S.)Sensitivity and Specificity Registries Odds Ratio Disease-Free Survival Age Factors Multivariate Analysis SEER Program Treatment Outcome Predictive Value of Tests Reproducibility of Results Kaplan-Meier Estimate Incidence Watchful Waiting Questionnaires Logistic Models Clinical Trials as Topic Cohort Studies Confidence Intervals Case-Control Studies American Cancer Society Nomograms Palliative Care Age Distribution

Geographicals4

United States Japan Sweden China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Prostatic Neoplasms Prostate-Specific Antigen Early Detection of Cancer Cell Line, Tumor Prostatic Hyperplasia Receptors, Androgen Androgens Gene Expression Regulation, Neoplastic Prostatectomy Androgen Antagonists Neoplasm Metastasis Mice, Nude Neoplasm Invasiveness Breast Neoplasms Tumor Markers, Biological Disease Progression Adenocarcinoma Ovarian Neoplasms Neoplasms, Hormone-Dependent Orchiectomy Lung Neoplasms Neoplasm Proteins Neoplasms Prostatic Intraepithelial Neoplasia Colonic Neoplasms Transurethral Resection of Prostate Stomach Neoplasms Antineoplastic Agents Reverse Transcriptase Polymerase Chain Reaction Neoplasm Staging Genetic Predisposition to Disease Prognosis Carcinoma RNA, Messenger Xenograft Model Antitumor Assays Cancer Vaccines Cell Proliferation Bone Neoplasms Neoplasm Transplantation Tumor Cells, Cultured Pancreatic Neoplasms Gene Expression Profiling Survival Analysis Neoplasm Grading Apoptosis Survival Rate Antineoplastic Agents, Hormonal Risk Follow-Up Studies Drug Resistance, Neoplasm Blotting, Western Retrospective Studies Transplantation, Heterologous Prospective Studies Neoplasm Recurrence, Local Risk Factors Risk Assessment United States National Cancer Institute (U.S.)Sensitivity and Specificity Antineoplastic Combined Chemotherapy Protocols RNA, Small Interfering Urinary Bladder Neoplasms Cell Transformation, Neoplastic Immunohistochemistry Tosyl Compounds Uterine Cervical Neoplasms DNA, Neoplasm Dihydrotestosterone Registries Cell Survival Cell Division Down-Regulation Anticarcinogenic Agents Mutation Cell Growth Processes Odds Ratio DNA Methylation Combined Modality Therapy Prostatic Diseases Disease-Free Survival Colorectal Neoplasms Biopsy Digital Rectal Examination Genotype Age Factors Cell Movement Oligonucleotide Array Sequence Analysis Receptors, Estrogen Signal Transduction Antigens, Neoplasm Tumor Burden Finasteride Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Mice, SCID Survivors Biopsy, Needle Receptor, erbB-2

No FAQ available that match "cancers detected prostate"